FDA InspectionJoseph L. Lillo, D.O.
Joseph L. Lillo, D.O. – FDA Inspection, Apr 12, 2017
Record Details
This FDA Inspection record concerns Joseph L. Lillo, D.O., with an inspection on April 12, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
ID · 46c8c5aa-ab63-47bd-8955-02f814c16650
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009886
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Joseph L. Lillo, D.O.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2021 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 9, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 17, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 26, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Or discuss it with
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Joseph L. Lillo, D.O. document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA